Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide

Placenta

Volumn 20, Issue 7, 1999, Pages 561-566

  Ejima, K ^a   Koji, T ^b   Nanri, H ^a   Kashimura, M ^a   Ikeda, M ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; CYTOKINE; LIPOPOLYSACCHARIDE; OXYGEN RADICAL; THIOREDOXIN; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECIDUA; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PRIORITY JOURNAL; TIME; TROPHOBLAST; WESTERN BLOTTING;

EID: 0032802807     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0415     Document Type: Article

References (29)

1. Athanassakis I, Blecker R. C, Paetkau V, Guilbert L, Barr P & Wegmann T (1987) The immuno-stimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells. J Immunol, 138, 37-44.
2. Björnstedt M, Xue J, Huang W, Akesson B & Holmgren A (1994) The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem, 269, 29 382-29 384.
3. Björnstedt M, Hamberg M, Kumar S, Xue J & Holmgren A (1995) Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem, 270, 11 761-11 764.
4. Chae HZ, Chung SJ & Rhee SG (1994) Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem, 269, 27 670-27 678.
5. Driggers PH, Ennist DL, Gleason SL, Mak WH, Marks MS, Levi BZ, Flanagan JR, Appella E & Ozato K (1990) An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA, 87, 3743-3747.
6. Ejima K, Nanri H, Toki N, Kashimura M & Ikeda M (1999) Localization of thioredoxin reductase and thioredoxin in normal placenta and their protective effect against oxidative stress. Placenta, 20, 95-101.
7. Feng L, Xia Y, Garcia GE, Hwang D & Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α and lipopolysaccharide. J Clin Invest, 95, 1669-1675.
8. Fernando MR, Nanri H, Yoshitake S, Nagata-kuno K, Minakami S (1992) Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells. Eur J Biochem, 209, 917-922.
9. Greig PC, Herbert WNP, Robinette BL & Teot LA (1995) Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol, 173, 1223-1227.
10. Heyborne K, Witkin SS & McGregor JA (1992) Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol, 167, 920-925.
11. 2-microgloburin transcripts at early stages of mouse development. J Immunol, 147, 2740-2750.
12. Kakinuma C, Kuwayama C, Kaga N, Futamura Y, Katsuki Y & Shibutani Y (1997) Trophoblastic apoptosis in mice with preterm delivery and its suppression by urinary trypsin inhibitor. Obstet Gynecol, 90, 117-124.
13. Koji T, Kobayashi N, Nakanishi Y, Yoshii A, Hashimoto S, Shibata Y, Anjiki N, Yamamoto R, Aoki A, Ueda T, Kanazawa S & Nakane PK (1994) Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cytochem, 27, 459-463.
14. Laham N, Brennecke SP & Rice GE (1997) Interleukin-8 release from human gestational tissue explants: the effects of lipopolysaccharide and cytokines. Biol Reprod, 57, 616-620.
15. Luthman M & Holmgren A (1982) Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry, 21, 6628-6633.
16. Mau BL & Powis G (1992) Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds. Biochem Pharmacol, 43, 1613-1620.
17. Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, Inamoto T, Yamaoka Y, Ozawa K & Yodoi J (1994) Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett, 42, 75-80.
18. Paradowska E, Blach-Olszewska Z & Gejdel E (1997) Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta, 18, 441-446.
19. Redman CWG (1986) Immunological disorders of human pregnancy. Oxford Rev Reprod Biol, 8, 223
20. Sachi Y, Hirota K, Masutani H, Toda K, Okamoto T, Takigawa M & Yodoi J (1995) Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunol Lett, 44, 189-193.
21. Scott JR & Beer AA (1976) Immunologic aspects of preeclampsia. Am J Obstet Gynecol, 125, 418-427.
22. Shiraishi H, Hayakawa A & Satoh K (1996) Murine experimental abortion by IL-2 administration is caused by activation of cytotoxic T-lymphocytes and placental apoptosis. J Clin Lab Immunol, 48, 93-108.
23. Taylor RN (1997) Immunology of preeclampsia. Am J Reprod Immunol, 37, 79-86.
24. Uchida K, Szweda LI, Chae HZ & Stadtman ER (1993) Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci USA, 90, 8742-8746.
25. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D & Redman CWG (1995) Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol, 102, 20-25.
26. Yamaguchi M, Imai T, Maeda T, Sakata M, Miyake A & Linzer DIH (1995) Cyclic adenosine 3,5,-monophosphate stimulation of placental proliferrin and proliferrin-related protein secretion. Endocrinology, 136, 2040-2046.
27. Yodoi J & Uchiyama T (1992) Diseases associated with HTLV-1: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today, 13, 405-411.
28. Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M & Kohno K (1995) Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res, 55, 4293-4296.
29. Yoshitake S, Nanri H, Fernando MR, Minakami S (1994) Possible differences in the regenerative roles played by thioltransferase and thioredoxin for oxidatively damaged proteins. J Biochem, 116, 42-46.